Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

NICE refuses to back Sanofi’s Jevtana

September 30, 2011 Sales and Marketing Jevtana, NICE

NICE has not recommended Sanofi’s prostate cancer drug Jevtana due to its high cost and concerns over its safety data. …
News

Merck pulls out of J&J consumer venture

September 29, 2011 Sales and Marketing J&J, JJ, Merc & Co, OTC

Merck & Co has exited a joint venture with J&J, selling its stake in the J&J/Merck Consumer Pharmaceuticals business to …
News

NICE blames pharma R&D model for spiralling cancer drug costs

September 29, 2011 Research and Development, Sales and Marketing Cancer, NICE, clincial trials

NICE has blamed the pharma industry’s ‘inefficient’ and increasingly costly R&D model for the rising price of cancer drugs. NICE …
News

Novartis’ brain tumour drug Votubia launched in UK

September 29, 2011 Sales and Marketing Afinitor, Votubia

Novartis has launched its orphan drug Votubia in the UK for patients with a rare type of brain tumour. Votubia …
News

Gardasil better value for money than Cervarix, finds new study

September 28, 2011 Sales and Marketing Cervarix, Gardasil, HPV, cervical cancer

A new report by the Health Protection Agency has found that Gardasil is a more cost-effective vaccine for cervical cancer …
News

Cancer costs on an ‘unaffordable trajectory’

September 28, 2011 Sales and Marketing Cancer, healthcare costs

The cost of cancer is rising too fast with new treatments giving uncertain benefits, according to a new study. A …
News

Bridgehead International appoints Marcus Deans

September 26, 2011 Sales and Marketing appointment, sales and marketing

London-based consultants Bridgehead International have appointed Marcus Deans as principal consultant. He joins the firm, which specialises in market access, …
Appointment

Xarelto poised for two new chronic indications

September 26, 2011 Sales and Marketing Xarelto

Bayer HealthCare’s oral bloodthinner Xarelto has been recommended for approval in Europe for two new chronic indications. The Committee for …
News

Roche’s Avastin set for new ovarian cancer indication in Europe

September 26, 2011 Sales and Marketing avastin, ovarian cancer

Roche’s Avastin has gained the backing of European regulatory advisors for a new indication in ovarian cancer. The European Medicines …
News

Safety concerns prompt Multaq restrictions

September 26, 2011 Sales and Marketing Multaq

The European Medicines Agency has recommended Sanofi’s Multaq be restricted due to ongoing concerns about its safety profile. The drug …
News

Avastin faces greater scrutiny over eye disease use

September 23, 2011 Sales and Marketing avastin, macular oedema

The use of Roche’s Avastin to treat eye disease has come under greater scrutiny after a series of infections in …
News

Roche cleared over rep conduct complaint

September 23, 2011 Sales and Marketing ABPI Code of Practice, Roche

Roche has been cleared by Code regulator the PMCPA of any wrongdoing after an NHS employee complained about the promotion …
News

Value-based pricing won’t encourage innovation, says ABPI

September 23, 2011 Sales and Marketing value-based pricing

The ABPI has come out against the government’s reforms of drug pricing in the UK, saying its plans need a …
News

NHS ‘wasted’ £625 million on modern insulin

September 23, 2011 Sales and Marketing diabetes, insulin

The NHS has wasted £625 million on modern insulin products over the last decade, according to a new report in …
News

Healthcare 2025: what the future holds for pharma

September 22, 2011 Manufacturing and Production, Research and Development, Sales and Marketing NHS reform, healthcare reform, healthcare spending, prescribing

We are in the middle of a huge upheaval where everything we know is being turned on its head. Welcome …
Feature
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026